Form D · Pharmaceuticals
Tacitus Therapeutics Inc.
West Palm Beach, FL · CIK 0001799226
Offering snapshot reported Jan 10, 2020 · SEC filing
- Reported sold
- $5M Offering amount: $10M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $2K Reported outside-investor minimum
- First sale
- Dec 31, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 10, 2020 | Initial | $5,002,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-357655
One investor was issued securities in consideration of the granting of an exclusive license from such investor to the issuer.
Source: Form D, filed Jan 10, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carter Cliff | Director, Executive |
| Jeffrey Kennedy | Director, Executive |
| Erik Lium | Director |
| Thomas Novak | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
C/O Summer Road Llc 207 6 Th Street
West Palm Beach, FL, 33401
West Palm Beach, FL, 33401